Nigel Theobald
Net worth: 146 549 $ as of 2026-06-29
Net worth: 146 549 $ as of 2026-06-29
Nigel James Theobald is the founder of Abaco Capital Plc, founded in 2009.
Mr. Theobald was the founder of N4 Pharma Plc, founded in 2014, and held the title of Chief Executive Officer & Executive Director from 2017 to 2026.
Mr. Theobald was the founder of N4 Pharma UK Ltd., founded in 2014, and held the title of Chief Executive Officer.
Mr. Theobald was a Non-Executive Director at Medherant Ltd. Mr. Theobald was Head-Healthcare Brands at Boots Group Plc.
Mr. Theobald completed undergraduate education at The University of Southampton.
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2025-04-22 | 16,981,319 ( 2.04% ) | 146 549 $ | 2026-06-29 |
| Companies | Position | End |
|---|---|---|
| THALIA THERAPEUTICS PLC | Founder | 2026-02-23 |
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Corporate Officer/Principal | - |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Director/Board Member | - |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Chief Executive Officer | - |
| ABACO CAPITAL PLC | Founder | - |
Active
Inactive
Listed companies
Private companies
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
| Private companies | 6 |
|---|---|
Boots Group Plc
Boots Group Plc Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical and consumer products | Health Technology |
The University of Southampton
The University of Southampton Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Abaco Capital Plc
Abaco Capital Plc Financial ConglomeratesFinance Operates as a shell company with no operations | Finance |
N4 Pharma Ltd.
N4 Pharma Ltd. Pharmaceuticals: GenericHealth Technology Operates as a drug reformulation company | Health Technology |
Medherant Ltd.
Medherant Ltd. Pharmaceuticals: MajorHealth Technology Develops transdermal drug delivery patches | Health Technology |
N4 Pharma Plc
N4 Pharma Plc BiotechnologyHealth Technology Provides specialist pharmaceutical services that reformulates existing drugs and vaccines to improve their performance | Health Technology |
Select your edition
All financial news and data tailored to specific country editions